GSK Plc
NYSE: GSK
$33.60
+$0.17 (+0.5%)
Closing Price on December 20, 2024
GSK Articles
Pfizer is scheduled to release its fourth-quarter financial results before the markets open on Tuesday. Consensus estimates call for modest year-over-year growth.
Published:
Last Updated:
GlaxoSmithKline shares bounced higher on Wednesday after the company announced a new joint venture with Pfizer. These two firms will create a premier global consumer health care company combining...
Published:
Last Updated:
Elon Musk previews Los Angeles transportation tunnel, Pfizer and GlaxoSmithKline team up, stock buybacks hit a record this year, and other important business headlines today.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday included Activision Blizzard, BioMarin Pharmaceuticals, Ciena, Delta Air Lines, GlaxoSmithKline, Procter & Gamble, Regeneron...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday included Alphabet, American Water, Apple, Facebook, Macy's, Southern Copper, Twitter and YY.
Published:
Last Updated:
Tesaro shares absolutely exploded early on Monday after the company announced that it has entered a definitive agreement to be acquired by GlaxoSmithKline.
Published:
Last Updated:
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in September.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday include Glaukos, Honeywell, Itau, MongoDB, 3M, PayPal, Salesforce.com, Tandem Diabetes Care, Vodafone and National Bank of Greece.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Monday include Applied Materials, Baker Hughes, Bloom Energy, Constellation Brands, Deere, JC Penney, Kroger, Nike and Tesla.
Published:
Last Updated:
With bond yields still very low, dividend-yielding total return stocks may be the way to play the rest of 2018. These five stocks are ideal for investors who want to own ones that they can put in...
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Thursday include Dolby Laboratories, Facebook, Freeport-McMoRan, Gilead, GrubHub and Skechers.
Published:
Last Updated:
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates in July.
Published:
Last Updated:
OSI Systems, Edison International, Cemex, and GlaxoSmithKline all posted new 52-week lows Wednesday.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Monday include AECOM, Ciena, Evoqua Water Tech, Funko, GlaxoSmithKline and Square.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Thursday include Barrick Gold, Buffalo Wild Wings, Caterpillar, Coca-Cola, GrubHub, Nabors Industries and Wynn Resorts.
Published:
Last Updated: